Recent research focusing on Semaglutide at a dosage of 30mg is shedding new light on its potential benefits. Early read more findings suggest that this higher dosage may boost the drug's ability to manage blood sugar, potentially offering greater outcomes for individuals with type 2 diabetes. Further research is underway to fully evaluate the long-